Calcipotriol

Author: Prof. Dr. med. Peter Altmeyer

Co-Autor: Dr. med. Florian Weid

All authors of this article

Last updated on: 05.05.2025

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Vitamin D3 analogue.

Pharmacodynamics (Effect)
This section has been translated automatically.

1,25-Dihydroxyvitamin D3 [1,25(OH)2D3] inhibits IL-12 production by activated macrophages and dendritic cells, providing a new interpretation of its immunosuppressive properties. 1,25(OH)2D3 significantly inhibits mRNA expression for the IL-12 subunits p35 and p40 at the transcriptional level. There is evidence of transcriptional inhibition of the p40 gene by 1,25(OH)2D3, which required co-expression of VDR with RXR and an intact VDR DNA-binding domain. The repressive effect can be attributed to a region in the p40 promoter that contains a binding site for NF-kappaB (p40-kappaB). Activation of monocytic THP-1 cells in the presence of 1,25(OH)2D3 leads to reduced binding to the p40-kappaB site. It can be assumed that 1,25(OH)2D3 negatively regulates IL-12 production by downregulating NF-kappaB activation and binding to the p40-kappaB sequence (D'Ambrosio D et al. 1998)

Indication
This section has been translated automatically.

Mild to moderate psoriasis vulgaris of the plaque type with an extension of < 30% of the body surface.

Dosage and method of use
This section has been translated automatically.

Ointment/cream/compound: Apply 2 times/day to the affected areas of skin (max. 30% of the body surface, max. 15 g ointment/cream/day, max. for 6 weeks) The cream base or a solution can also be used in the area of the capillitium, as it can be washed out easily!

Standard concentration
This section has been translated automatically.

0.005% in lotions, ointments, creams.

Undesirable effects
This section has been translated automatically.

Cream/ointment: Occasional temporary itching, burning and erythema, especially in intertriginous areas. Occurrence of facial and perioral dermatitis (see also eczema, contact dermatitis, allergic dermatitis), which subside after the end of treatment. Continuous use in high doses may lead to hypercalcemia and/or increased calcium excretion in the urine.

Solution: S.o., in addition possibly worsening of psoriasis, photosensitivity, rarely hypercalcemia, hypercalciuria.

Disseminated molluscum contagiosum infections have occasionally been observed in psoriatic patients under combined calipotriol/betamethasone ointment therapy (Ji Young Ahn 2020)

Interactions
This section has been translated automatically.

Calcium preparations, salicylic acid, cream bases without active ingredients.

Contraindication
This section has been translated automatically.

Pregnancy, lactation, children and adolescents < 18 years, large-area application (> 30% KO), psoriasis punctata, pustular psoriasis, diseases of the calcium metabolism, severe liver and kidney diseases.

Incompatibility
This section has been translated automatically.

Exteriors containing salicylic acid inactivate calcipotriol when used simultaneously and even after hours of use.

Preparations
This section has been translated automatically.

Daivonex® - cream, ointment, solution

Daivobet® - gel, ointment (combination with betamethasone dipropionate)

Xamiol® - gel (combination with betamethasone dipropionate)

Enstilar® - foam (spray foam galenic, also combination with betamethasone diproprionate)

Dovobet® - gel (combination with betamethasone diproprionate)

Calcipotriol - Solution

Calcipotriol Comp - Ointment

Patientinformation
This section has been translated automatically.

Wash your hands after use to avoid transfer to the facial skin and other non-diseased skin areas!

Literature
This section has been translated automatically.

  1. D'Ambrosio D et al. (1998) Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 101:252-262.
  2. Bae JY et al. (2020) A case of disseminated molluscum contagiosum caused by topical calcipotriol/betamethasone in an immunocompetent adult. J Dtsch Dermatol Ges 18:44-46.

Authors

Last updated on: 05.05.2025